Article Information
History
- October 2, 2020.
Article Versions
- Version 1 (September 25, 2020 - 08:03).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Naveen K. Singha,†,
- Partha Rayb,†,
- Aaron F. Carlinc,
- Celestine Magallanesd,
- Sydney C. Morgand,
- Louise C. Laurentd,
- Eliah S. Aronoff-Spencerc,* and
- Drew A. Halla,e,*
- aDepartment of Electrical and Computer Engineering, University of California – San Diego, La Jolla, CA 92093, USA
- bDivision of Surgical Oncology, Department of Surgery, Moores Cancer Center, University of California – San Diego Health, La Jolla, CA 92093, USA
- cDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California – San Diego, La Jolla, CA 92093, USA
- dDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California – San Diego, La Jolla, CA 92093, USA
- eDepartment of Bioengineering, University of California – San Diego, La Jolla, CA 92093, USA
- ↵*Corresponding authors, address correspondence to: earonoffspencer{at}health.ucsd.edu, drewhall{at}ucsd.edu
↵† Equal contribution
Author contributions: N.K.S., P.R., E.A.S., and D.A.H. concept conceptualization; N.K.S., P.R., and A.F.C. experiments; N.K.S., P.R., E.A.S., and D.A.H. data analysis; C.M., S.M., and L.C.L. SARS-CoV-2 clinical samples; E.A.S. and D.A.H. wrote the manuscript with contribution from all other authors.